FOXO1: A Potential Target for Human Diseases

被引:86
|
作者
Lu, Huarui [2 ]
Huang, Haojie [1 ,2 ,3 ]
机构
[1] SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA
[2] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
FoxO transcription factors; posttranslational modification; apoptosis; the cell cycle; glucose metabolism; cancer; diabetes; muscle atrophy; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE-B; PROSTATE-CANCER CELLS; FACTOR FKHR; ANDROGEN RECEPTOR; LIFE-SPAN; NUCLEAR EXCLUSION; SKELETAL-MUSCLE; FAMILY-MEMBER; DNA-BINDING;
D O I
10.2174/138945011796150280
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The forkhead box O (FoxO) transcription factors are known to be involved in many physiological and pathological processes including apoptosis, cell cycle arrest, stress resistance, glucose metabolism, cellular differentiation and development, and tumor suppression. The environmental cues, such as growth factors, nutrients, oxidative stress and irradiation, can either positively or negatively modulate FoxO proteins' activities, thereby ensuring distinctive transcription programs in the cell. The potent activities of FoxOs are tightly controlled by multiple mechanisms, which include posttranslational modification such as phosphorylation, acetylation, methylation and ubiquitination, subcellular localization, and direct protein-protein interaction. Mounting evidence suggests that the human FOXO1 protein, a founding member of the FoxO family is likely involved in carcinogenesis, diabetes and other human diseases. Here we give an overview of most recent findings regarding the regulation and function of FoxO1, its potential role in human diseases and useful animal models for functional studies on FoxO1. Prospective ways in which the discoveries from the basic research of FoxO1 can be utilized for drug targeting and development of novel therapeutics for human diseases are also discussed.
引用
收藏
页码:1235 / 1244
页数:10
相关论文
共 50 条
  • [21] FOXO1 Expression Is Reduced in Human Pituitary Adenomas.
    Farris, C. L.
    Jung, D. O.
    Lloyd, R. V.
    Ellsworth, B. S.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [22] FoxO1 enhances differentiation and apoptosis in human primary keratinocytes
    Shi, Ge
    Liao, Pei-Yu
    Cai, Xiao-Lin
    Pi, Xiao-Xue
    Zhang, Man-Feng
    Li, Shi-Jie
    Quan, Juan-Hua
    Fan, Yi-Ming
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (11) : 1254 - 1260
  • [23] Localisation and Expression of FoxO1 Proteins in Human Gestational Tissues
    Lappas, M.
    Lim, R.
    Riley, C.
    Rice, G. E.
    Permezel, M.
    PLACENTA, 2009, 30 (03) : 256 - 262
  • [24] Genome-wide analysis of FoxO1 binding in hepatic chromatin: Potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis
    Shin, Dong-Ju
    Joshi, Pujan
    Hong, Seung-Hyun
    Mosure, Kathleen
    Shin, Dong-Guk
    Osborne, Timothy F.
    NUCLEIC ACIDS RESEARCH, 2012, 40 (22) : 11499 - 11509
  • [25] Exploration the potential mechanism of the SIRT1 and its target gene FOXO1/PPARGC1A in uteropelvic junction obstruction
    Zhao, Qian
    Liu, Ge
    Yin, Xiaoming
    Fan, Xu
    Yang, Yi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (11) : 4192 - +
  • [26] Exploring the Potential of Natural Products as FoxO1 Inhibitors : an In Silico Approach
    Gupta, Anugya
    Haldhar, Rajesh
    Agarwal, Vipul
    Rajput, Dharmendra Singh
    Chun, Kyung-Soo
    Han, Sang Beom
    Raj, Vinit
    Lee, Sangkil
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (03) : 390 - 398
  • [27] FoxO1 as a tissue-specific therapeutic target for type 2 diabetes
    Teaney, Nicole A.
    Cyr, Nicole E.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [28] A global perspective on FOXO1 in lipid metabolism and lipid-related diseases
    Li, Yue
    Ma, Zhiqiang
    Jiang, Shuai
    Hu, Wei
    Li, Tian
    Di, Shouyin
    Wang, Dongjin
    Yang, Yang
    PROGRESS IN LIPID RESEARCH, 2017, 66 : 42 - 49
  • [29] FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondria! Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells
    He, Wei
    Zhang, Aiqing
    Qi, Lei
    Na, Chen
    Jiang, Rui
    Fan, Zhining
    Chen, Jianping
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (04) : 1506 - 1514
  • [30] miR-139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytes
    Hasseine, Larbi Kamal
    Hinault, Charlotte
    Lebrun, Patricia
    Gautier, Nadine
    Paul-Bellon, Rachel
    Van Obberghen, Emmanuel
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 390 (04) : 1278 - 1282